Noho (DRNK) Inventory Turnover Ratio, from third quarter 2014 to third quarter 2013, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Noho, Inc.  (DRNK)
 

Noho Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2014, Noho's inventory turnover ratio sequentially decreased to 3.17 in the third quarter 2014, unsurprisingly, as the Noho markets continue to deteriorate, and DRNK's faces growing challenges to bring down its inventories. Noho's average inventory processing period in the Sep 30 2014 quarter, has increased to 115 days, from 85 days, in the Jun 30 2014 quarter.

Within Healthcare sector 119 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2014, to 1276, from total ranking in the second quarter 2014 at 1483.

DRNK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Noho, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DRNK Inventory Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Inventory Growth 35.19 % -49.04 % - - -
Y / Y Cost of Sales Growth -84.86 % -28.5 % -48.89 % - -
Inventory Turnover Ratio (TTM) 3.17 4.27 3.69 5.19 4.27
DRNK's Total Ranking # 1276 # 1483 # 1483 # 0 # 0
Average inventory processing period 115 86 99 70 85
Seq. Inventory Growth 87.96 % -0.7 % -31.43 % 5.63 % -29.14 %
Seq. Cost of Sales Growth -65.63 % -46.5 % -65.87 % 141.24 % 62.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 120
Overall Market # 1276

Inventory Turnover Ratio Statistics
High Average Low
4.27 3.71 3.17
(Jun 30 2014)   (Sep 30 2014)



DRNK Company Profile >> Back to DRNK Efficiency Comparisons >> Compare DRNK Inventory Turnover Ratio to its Competitors

Financial Statements
Noho's Inventories $ 0 Millions Visit DRNK's Balance sheet
Noho's Cost of Revenues TTM $ 0 Millions Visit DRNK's Income Statement
What are DRNK's Sales? Visit DRNK's Sales by Segment

Other Inventory Turnover Ratios
Noho's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DRNK's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DRNK's Competitors
Inventory Turnover Ratio for DRNK's Suppliers
Inventory Turnover Ratio for DRNK's Customers

You may also want to know
DRNK's Sales Growth Rates DRNK's Pe Price to earnings ratio DRNK's Receivables Turnover Ratio DRNK's Stock Quote
DRNK's Net Income Growth Rates DRNK's Ps Price to Sales ratio DRNK's Sales per Employee DRNK's Asset Turnover Ratio
DRNK's Net Margin DRNK's Pb Price to Book ratio DRNK's Financial Strength Ratios DRNK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2014 Inventories at quarter ending Sep 30 2014
Biorestorative Therapies Inc   6.11 $ 0.109  Millions$ 0  Millions
Charles River Laboratories International inc   5.93 $ 543.459  Millions$ 92  Millions
Fibrocell Science, Inc.  5.93 $ 3.244  Millions$ 1  Millions
Carlisle Companies Incorporated  5.68 $ 1,828.300  Millions$ 322  Millions
Teligent Inc   5.49 $ 15.750  Millions$ 3  Millions
West Pharmaceutical Services Inc   5.33 $ 983.900  Millions$ 185  Millions
Global Cord Blood Corp  5.20 $ 22.032  Millions$ 4  Millions
Invacare Holdings Corporation  5.18 $ 840.571  Millions$ 162  Millions
Lifeloc Technologies Inc   5.16 $ 4.666  Millions$ 1  Millions
Cantel Medical Corp   5.15 $ 299.665  Millions$ 58  Millions
Vertex Pharmaceuticals Inc  5.11 $ 69.224  Millions$ 14  Millions
Ligand Pharmaceuticals Incorporated  4.93 $ 6.450  Millions$ 1  Millions
Tearlab Corp  4.93 $ 9.713  Millions$ 2  Millions
Perrigo Company Plc  4.83 $ 3,242.613  Millions$ 671  Millions
Cyteir Therapeutics Inc   4.81 $ 1,337.600  Millions$ 278  Millions
Teva Pharmaceutical Industries Limited  4.64 $ 11,784.000  Millions$ 2,537  Millions
Chembio Diagnostics Inc   4.64 $ 17.236  Millions$ 4  Millions
Idexx Laboratories Inc  4.62 $ 665.306  Millions$ 144  Millions
Enzo Biochem Inc  4.45 $ 39.369  Millions$ 9  Millions
Nanostring Technologies Inc   4.40 $ 29.095  Millions$ 7  Millions
Heska Corporation  4.34 $ 52.941  Millions$ 12  Millions
Amarin Corp Plcuk  4.32 $ 18.736  Millions$ 4  Millions
Icu Medical Inc  4.26 $ 156.644  Millions$ 37  Millions
Igc Pharma Inc   4.17 $ 2.636  Millions$ 1  Millions
Pacira Biosciences inc   4.17 $ 76.848  Millions$ 18  Millions
Adicet Bio Inc   4.17 $ 403.101  Millions$ 97  Millions
Bausch Health Companies Inc   4.16 $ 2,896.230  Millions$ 697  Millions
3m Company  4.13 $ 16,396.000  Millions$ 3,969  Millions
Alerislife Inc   4.10 $ 1,498.973  Millions$ 366  Millions
Precipio inc   4.09 $ 15.949  Millions$ 4  Millions

Date modified: 2026-06-22T14:31:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.